These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 2649340)

  • 1. The influence of different insulin regimens on quality of life and metabolic control in insulin-dependent diabetics.
    Tallroth G; Karlson B; Nilsson A; Agardh CD
    Diabetes Res Clin Pract; 1989 Jan; 6(1):37-43. PubMed ID: 2649340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized trial of the efficacy and acceptability of a pen injector.
    Murray DP; Keenan P; Gayer E; Salmon P; Tomkin GH; Drury MI; O'Sullivan DJ
    Diabet Med; 1988 Nov; 5(8):750-4. PubMed ID: 2975567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A bolus/basal multiple injection regimen in type I diabetes. A multicentre trial using a new 'fountain-pen' device for short-acting human insulin as well as long-acting human insulin.
    Distiller LA; Robertson LI; Moore R; Bonnici F
    S Afr Med J; 1987 Jun; 71(12):749-52. PubMed ID: 3299758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A pen-injector of insulin in young diabetics: freedom and excessive weight gain].
    Dorchy H
    Pediatrie; 1988; 43(8):697-702. PubMed ID: 3065723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of different insulin regimens in elderly patients with NIDDM.
    Wolffenbuttel BH; Sels JP; Rondas-Colbers GJ; Menheere PP; Nieuwenhuijzen Kruseman AC
    Diabetes Care; 1996 Dec; 19(12):1326-32. PubMed ID: 8941458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin regimens for the non-insulin dependent: impact on diurnal metabolic state and quality of life.
    Taylor R; Foster B; Kyne-Grzebalski D; Vanderpump M
    Diabet Med; 1994 Jul; 11(6):551-7. PubMed ID: 7955971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Response to intensive therapy steps and to glipizide dose in combination with insulin in type 2 diabetes. VA feasibility study on glycemic control and complications (VA CSDM).
    Abraira C; Henderson WG; Colwell JA; Nuttall FQ; Comstock JP; Emanuele NV; Levin SR; Sawin CT; Silbert CK
    Diabetes Care; 1998 Apr; 21(4):574-9. PubMed ID: 9571345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of intensified insulin regimen on quality of life and metabolic control in insulin-dependent diabetes mellitus.
    Karlson B; Agardh CD
    Diabetes Res Clin Pract; 1994 Sep; 25(2):111-5. PubMed ID: 7821190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of bedtime insulin regimens in patients with type 2 diabetes mellitus. A randomized, controlled trial.
    Yki-Järvinen H; Ryysy L; Nikkilä K; Tulokas T; Vanamo R; Heikkilä M
    Ann Intern Med; 1999 Mar; 130(5):389-96. PubMed ID: 10068412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of biphasic insulin aspart 30 given three times daily or twice daily in combination with metformin versus oral antidiabetic drugs alone in patients with poorly controlled type 2 diabetes: a 16-week, randomized, open-label, parallel-group trial conducted in russia.
    Ushakova O; Sokolovskaya V; Morozova A; Valeeva F; Zanozina O; Sazonova O; Zhadanova E; Starceva M; Kazakova E; Saifullina M; Shapiro I; Tarasov A; Al-Tayar B; Starkova N
    Clin Ther; 2007 Nov; 29(11):2374-84. PubMed ID: 18158078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experiences with functional insulin substitution: a follow-up study on control and patient compliance.
    Fövényi J; Szövérffy G; Thaisz E; Lehotkai L; Wettstein A
    Acta Med Hung; 1992-1993; 49(1-2):53-64. PubMed ID: 1296187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of insulin lispro in combination with NPH human insulin twice per day in patients with insulin-dependent or non-insulin-dependent diabetes mellitus. Multicenter Insulin Lispro Study Group.
    Vignati L; Anderson JH; Iversen PW
    Clin Ther; 1997; 19(6):1408-21. PubMed ID: 9444449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and acceptance of two intensified conventional insulin therapy regimens: a long-term cross-over comparison.
    Houtzagers CM; Berntzen PA; van der Stap H; van Maarschalkerweerd WW; Lanting P; Boen-Tan I; Heine RJ; van der Veen EA
    Diabet Med; 1989 Jul; 6(5):416-21. PubMed ID: 2527678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two or three insulin injections in adolescence?
    Hinde FR; Johnston DI
    Arch Dis Child; 1986 Feb; 61(2):118-23. PubMed ID: 3513719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long term feasibility of multiple daily injections with insulin pens in children and adolescents with diabetes.
    Tubiana-Rufi N; Levy-Marchal C; Mugnier E; Czernichow P
    Eur J Pediatr; 1989 Nov; 149(2):80-3. PubMed ID: 2686997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple daily insulin injections improve self-confidence.
    Houtzagers CM; Visser AP; Berntzen PA; van der Stap H; van Maarschalkerweerd WW; Heine RJ; van der Veen EA
    Diabet Med; 1989 Aug; 6(6):512-9. PubMed ID: 2527133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short-term intensive insulin therapy could be the preferred option for new onset Type 2 diabetes mellitus patients with HbA1c > 9.
    Weng J
    J Diabetes; 2017 Oct; 9(10):890-893. PubMed ID: 28661564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL; Figgitt DP
    Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of conventional twice daily subcutaneous insulin administration and a multiple injection regimen (using the NovoPen) in insulin-dependent diabetes mellitus.
    Small M; MacRury S; Boal A; Paterson KR; MacCuish AC
    Diabetes Res; 1988 Jun; 8(2):85-9. PubMed ID: 3067951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mealtime 50/50 basal + prandial insulin analogue mixture with a basal insulin analogue, both plus metformin, in the achievement of target HbA1c and pre- and postprandial blood glucose levels in patients with type 2 diabetes: a multinational, 24-week, randomized, open-label, parallel-group comparison.
    Robbins DC; Beisswenger PJ; Ceriello A; Goldberg RB; Moses RG; Pagkalos EM; Milicevic Z; Jones CA; Sarwat S; Tan MH
    Clin Ther; 2007 Nov; 29(11):2349-64. PubMed ID: 18158076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.